{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:46:43Z","timestamp":1790794003153,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.eplepsyres.2011.05.003","type":"journal-article","created":{"date-parts":[[2011,6,22]],"date-time":"2011-06-22T04:48:13Z","timestamp":1308718093000},"page":"81-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: A Population-Based National Health Insurance study"],"prefix":"10.1016","volume":"96","author":[{"given":"Liang-Po","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eplepsyres.2009.03.002","article-title":"Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003\u2fff2005","volume":"85","author":"Alacqua","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/155005940703800214","article-title":"Antiepileptic drugs and mood stability","volume":"38","author":"Amann","year":"2007","journal-title":"Clin. EEG Neurosci."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0015","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ncl.2010.03.026","article-title":"The selection of antiepileptic drugs for the treatment of epilepsy in children and adults","volume":"28","author":"Asconape","year":"2010","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0020","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(04)00882-8","article-title":"Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines","volume":"3","author":"Beghi","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0025","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/pds.1825","article-title":"US physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey","volume":"18","author":"Chen","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1472-6963-6-54","article-title":"Patterns of ambulatory care utilization in Taiwan","volume":"6","author":"Chen","year":"2006","journal-title":"BMC Health Services Res."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1377\/hlthaff.22.3.61","article-title":"Taiwan's new national health insurance program: genesis and experience so far","volume":"22","author":"Cheng","year":"2003","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0040","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1176\/ps.2007.58.4.554","article-title":"Trends in the use of psychotropic drugs in Taiwan: a population-based national health insurance study, 1997\u2fff2004","volume":"58","author":"Chien","year":"2007","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0045","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1176\/appi.ps.55.6.691","article-title":"Prevalence of psychiatric disorders among National Health Insurance enrollees in Taiwan","volume":"55","author":"Chien","year":"2004","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nurt.2006.10.003","article-title":"Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain","volume":"4","author":"Ettinger","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eplepsyres.2008.11.018","article-title":"Antiepileptic drug utilization in Taiwan: Analysis of prescription using National Health Insurance database","volume":"84","author":"Hsieh","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.07.005","article-title":"Antiepileptic drugs in epilepsy and other disorders \u2fff a population-based study of prescriptions","volume":"87","author":"Landmark","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0065","first-page":"29","article-title":"Drug-treatment of uncontrolled seizures","author":"Mattson","year":"1992","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.yebeh.2009.04.026","article-title":"Antiepileptic drug use in women of childbearing age","volume":"15","author":"Meador","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0447.2005.00523.x","article-title":"Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder","volume":"111","author":"Muzina","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1468-1331.2006.01268.x","article-title":"Use of antiepileptic drugs in Estonia: an epidemiologic study of adult epilepsy","volume":"13","author":"Oun","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1034\/j.1600-0404.2001.00197.x","article-title":"Antiepileptic drug utilization: a Danish prescription database analysis","volume":"104","author":"Rochat","year":"2001","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0090","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1468-1331.2007.01970.x","article-title":"Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000\u2fff2005","volume":"14","author":"Savica","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0095","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","article-title":"Topiramate in migraine prevention \u2fff results of a large controlled trial","volume":"61","author":"Silberstein","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/j.1950-6945.2004.tb00053.x","article-title":"Antiepileptic drugs: indications other than epilepsy","volume":"6","author":"Spina","year":"2004","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0105","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJMp0802107","article-title":"Regulating off-label drug use \u2fff rethinking the role of the FDA","volume":"358","author":"Stafford","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0110","first-page":"294","article-title":"Patterns of anti-epileptic drug use in Scottish Primary Care","volume":"70","author":"Tigalya","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin. Result from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"J. Pain"},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0404.2006.00639.x","article-title":"Trends in utilization of antiepileptic drugs in Denmark","volume":"113","author":"Tsiropoulos","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0125","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00228-008-0480-z","article-title":"Antiepileptic drug utilization in children from 1997\u2fff2005 \u2fff a study from the Netherlands","volume":"64","author":"van de Vrie-Hoekstra","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2011.05.003_bib0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0404.2006.00705.x","article-title":"Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?","volume":"114","author":"Zaccara","year":"2006","journal-title":"Acta Neurol. Scand."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121111001239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121111001239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:25:27Z","timestamp":1760275527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121111001239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0920121111001239"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.05.003","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: A Population-Based National Health Insurance study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}